A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 273
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PLN
Long Form : phospholamban
No. Year Title Co-occurring Abbreviation
2019 Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors. I/R, PLNKO, SR
2019 An Aptamer-Based Near-Infrared Fluorescence Nanoprobe for Detecting and Imaging of Phospholamban Micropeptide in Cardiomyocytes. lncRNAs
2019 Cardiac adenylyl cyclase overexpression precipitates and aggravates age-related myocardial dysfunction. AC8, NTG, TDI
2019 Contributions of Rho-kinase and AMP-related kinase (AMPK) Signaling Pathways to Endothelium-Derived Contracting Factors (EDCF)-mediated Responses in Diabetic Rat Aorta. ACC, AMPK, AMPK, EDCF, ROCKII, SERCA2, STZ
2019 Early calcium handling imbalance in pressure overload-induced heart failure with nearly normal left ventricular ejection fraction. CaMKII, HFpEF, SERCA2a
2019 Effects of tetrahydrobiopterin combined with nebivolol on cardiac diastolic function in SHRs. 3-NT, cGMP, DHE, eNOS, NO, PKG, ROS, SERCA2a, SHRs
2019 Increase in phospholamban content in mouse skeletal muscle after denervation. FDB, SERCA, SR, TA
2019 Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imaging. CMR, LGE, LV, LVEF, RV, VA
2019 Nitroxyl (HNO) targets phospholamban cysteines 41 and 46 to enhance cardiac function. SERCA2a, SR
10  2019 Phospholamban deficiency does not alter skeletal muscle SERCA pumping efficiency or predispose mice to diet-induced obesity. SLN, SOL, WT
11  2019 Pomolic acid reduces contractility and modulates excitation-contraction coupling in rat cardiomyocytes. ECC, PA, SR
12  2019 Prevalence and cardiac phenotype of patients with aphospholamban mutation. ---
13  2019 TGR5 activation ameliorates hyperglycemia-induced cardiac hypertrophy in H9c2 cells. LCA, PKA
14  2019 The intramembrane protease SPPL2c promotes male germ cell development by cleavingphospholamban. SERCA2, SPP, SPPL
15  2019 The Phospholamban Pentamer Alters Function of the Sarcoplasmic Reticulum Calcium Pump SERCA. ---
16  2018 CRABP1 protects the heart from isoproterenol-induced acute and chronic remodeling. CaM, CaMKII, CRABP1, ISO
17  2018 Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy. ACM, ARVC, DCM, IF
18  2018 Effects of the Arg9Cys and Arg25Cys mutations on phospholamban's conformational equilibrium in membrane bilayers. DCM, PKA
19  2018 Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca2+ cycling in vivo. DKO, DMD, PLNKO
20  2018 Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes. CAT, DCM, eNOS, GPx-1, NF-kappaB, Nrf2, PKK, SERCA2, SOD, STZ
21  2018 Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes. DCM, hECTs, hiPSC
22  2018 Gene expression and gene associations during the development of heart failure with preserved ejection fraction in the Dahl salt sensitive model of hypertension. ACE, ADM, AGT, ANP, AT1R, beta-MHC, BNP, CTGF, ECE1, ECM, ET-1, FLT1, HFpEF, ICAM-1, IL-1beta, iNOS, MCP-1, MMP13, MMP14, MMP2, TGF-beta1, TIMP1, TIMP2, VCAM1
23  2018 Impaired Ca2+ cycling of nonischemic myocytes contributes to sarcomere dysfunction early after myocardial infarction. I/R
24  2018 Muscle differentiation induced up-regulation of calcium-related gene expression in quail myoblasts. CASQ2, Cav-3, MYL1, NGS, qRT-PCR, TNNC1
25  2018 Protection against reperfusion injury by 3',4'-dihydroxyflavonol in rat isolated hearts involves inhibition of phospholamban and JNK2. DiOHF
26  2018 The antiapoptotic protein HAX-1 mediates half of phospholamban's inhibitory activity on calcium cycling and contractility in the heart. HAX-1, SERCA2a, SR
27  2018 The Dipeptidyl Peptidase 4 Substrate CXCL12 Has Opposing Cardiac Effects in Young Mice and Aged Diabetic Mice Mediated by Ca2+ Flux and Phosphoinositide 3-Kinase gamma. CXCL12, DPP-4, GLP-1, GLP-1R
28  2018 The DWORF micropeptide enhances contractility and prevents heart failure in a mouse model of dilated cardiomyopathy. DCM, MLP, SR
29  2018 The SarcoEndoplasmic Reticulum Calcium ATPase. ER, SLN, SR
30  2017 1H-detected MAS solid-state NMR experiments enable the simultaneous mapping of rigid and dynamic domains of membrane proteins. CP, MAS, SSNMR
31  2017 A pyridone derivative activates SERCA2a by attenuating the inhibitory effect of phospholamban. SERCA2a, SR
32  2017 A Sarcoplasmic Reticulum Localized Protein Phosphatase Regulates Phospholamban Phosphorylation and Promotes Ischemia Reperfusion Injury in the Heart. ---
33  2017 Ca2+/Calmodulin-Dependent Protein Kinase II and Androgen Signaling Pathways Modulate MEF2 Activity in Testosterone-Induced Cardiac Myocyte Hypertrophy. AR, CaMKII, MEF2
34  2017 Distinct fibrosis pattern in desmosomal and phospholamban mutation carriers in hereditary cardiomyopathies. LV
35  2017 Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes. CV, LV, SGLT2
36  2017 Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. ARVD/C, ECG, IQR, LV, LVEF, OR, RV, RVFAC, TFC
37  2017 Interleukin-18 gene deletion protects against sepsis-induced cardiac dysfunction by inhibiting PP2A activity. IL-18, IL-18 KO, LPS, LV, PP2A, WT
38  2017 Phospholamban immunostaining is a highly sensitive and specific method for diagnosing phospholamban p.Arg14del cardiomyopathy. LVAD
39  2017 Phospholamban Inhibition by a Single Dose of Locked Nucleic Acid Antisense Oligonucleotide Improves Cardiac Contractility in Pressure Overload-Induced Systolic Dysfunction in Mice. ASOs, FS, HF, LNA
40  2017 Phospholamban Is Downregulated by pVHL-Mediated Degradation through Oxidative Stress in Failing Heart. CCCP, DCM, MMP, pVHL, VHL
41  2017 Potential new mechanisms of pro-arrhythmia in arrhythmogenic cardiomyopathy: focus on calcium sensitive pathways. ARVC, CaMKII, CnA
42  2017 Probing the Conformationally Excited States of Membrane Proteins via 1H-Detected MAS Solid-State NMR Spectroscopy. ---
43  2017 Sarcolipin deletion exacerbates soleus muscle atrophy and weakness in phospholamban overexpressing mice. PlnOE, SLN
44  2017 Tead1 is required for maintaining adult cardiomyocyte function, and its loss results in lethal dilated cardiomyopathy. CM, iPS-derived
45  2016 Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans. CSRP3, FHL1, GLA, HCM, LAMP2, LMNA, NYHA, TNNT2, TPM1
46  2016 Diaphragm assessment in mice overexpressing phospholamban in slow-twitch type I muscle fibers. CNM, SLN
47  2016 Genomic correction of familial cardiomyopathy in human engineered cardiac tissues. ---
48  2016 Global phosphoproteomic profiling reveals perturbed signaling in a mouse model of dilated cardiomyopathy. DCM, R9C, SERCA2A
49  2016 Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. AA, ALEF, ARVD/C, CMR, ICD, PKP2, RA
50  2016 Intensive training and reduced volume increases muscle FXYD1 expression and phosphorylation at rest and during exercise in athletes. CaMKII, mTOR
51  2016 Molecular inotropy mediated by cardiac miR-based PDE4D/PRKAR1alpha/phosphoprotein signaling. cTnI, miR, PDE4D
52  2016 Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies. DCM
53  2016 Myocardial Response to Milrinone in Single Right Ventricle Heart Disease. PDE, PDE3i, RV
54  2016 Phospholamban ablation rescues the enhanced propensity to arrhythmias of mice with CaMKII-constitutive phosphorylation of RyR2 at site S2814. PLNKO, SR
55  2016 Phospholamban Ablation Using CRISPR/Cas9 System Improves Mortality in a Murine Heart Failure Model. Cas, CRISPR, CSQ-Tg, KO, SERCA2a
56  2016 Phospholamban degradation is induced by phosphorylation-mediated ubiquitination and inhibited by interaction with cardiac type Sarco(endo)plasmic reticulum Ca(2+)-ATPase. IBMX, ISO, PKA
57  2016 Phospholamban spontaneously reconstitutes into giant unilamellar vesicles where it generates a cation selective channel. FCS, GUVs, LSCM
58  2016 Pleiotropic Effects of Simvastatin on Some Calcium Regulatory and Myofibrillar Proteins in Ischemic/Reperfused Heart: Causality of Statins Cardioprotection? CaMKIIdelta, cMyBP-C, I/R, PP1beta, PP2A
59  2016 Reversal of Phospholamban Inhibition of the Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) Using Short, Protein-interacting RNAs and Oligonucleotide Analogs. miRNAs, XNAs
60  2016 Selective phosphorylation of PKA targets after beta-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model. beta-AR, cTnI, HCM, HET, ISO, PKA
61  2016 Urotensin II induction of neonatal cardiomyocyte hypertrophy involves the CaMKII/PLN/SERCA 2a signaling pathway. CaMKII, UII
62  2016 Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides. ALN, ELN, MLN, SLN
63  2015 A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. MLN, SLN, SR
64  2015 A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations. SERCA
65  2015 Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway. l-NAME
66  2015 Catestatin exerts direct protective effects on rat cardiomyocytes undergoing ischemia/reperfusion by stimulating PI3K-Akt-GSK3beta pathway and preserving mitochondrial membrane potential. Cst, I/R, MMP, NO, WM
67  2015 Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy. iPSCs, TALENs
68  2015 Effects of naturally occurring arginine 14 deletion on phospholamban conformational dynamics and membrane interactions. SERCA
69  2015 Metformin increases degradation of phospholamban via autophagy in cardiomyocytes. CMNCs
70  2015 PHD2/3-dependent hydroxylation tunes cardiac response to beta-adrenergic stress via phospholamban. CaMKII, NCOR2, PHD, TRalpha
71  2015 Phospholamban pentamers attenuate PKA-dependent phosphorylation of monomers. PKA, SERCA2a
72  2015 Regulation of the sarcoplasmic reticulum calcium pump by divergent phospholamban isoforms in zebrafish. SERCA, SLN, ZF
73  2015 Rheostatic Regulation of the SERCA/Phospholamban Membrane Protein Complex Using Non-Coding RNA and Single-Stranded DNA oligonucleotides. ssDNAs
74  2015 Sarcolipin and phospholamban inhibit the calcium pump by populating a similar metal ion-free intermediate state. MD, SLN
75  2015 The Modulation of Cardiac Contractile Function by the Pharmacological and Toxicological Effects of Urocortin2. aSvg-30, PKA, PS, Ucn2
76  2015 The regulation of sarco(endo)plasmic reticulum calcium-ATPases (SERCA). miRNAs, SERCA, SLN, SR
77  2015 [Decreased expression of calcium-sensing receptor involved in the progression of diabetic cardiomyopathy]. CaSR
78  2014 Binding of a monoclonal antibody to the phospholamban cytoplasmic domain interferes with the channel activity of phospholamban reconstituted in a tethered bilayer lipid membrane. tBLM
79  2014 CaMKII-dependent phosphorylation of cardiac ryanodine receptors regulates cell death in cardiac ischemia/reperfusion injury. I/R, S2814A, SR
80  2014 Development of a Sensitive Assay for SERCA Activity Using FRET Detection of ADP. TR-FRET
81  2014 Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses. Epac
82  2014 High resolution systematic digital histological quantification of cardiac fibrosis and adipose tissue in phospholamban p.Arg14del mutation associated cardiomyopathy. ---
83  2014 Integrin-linked kinase mediates force transduction in cardiomyocytes by modulating SERCA2a/PLN function. DCM, ILK, SERCA-2a
84  2014 Phospholamban interactome in cardiac contractility and survival: A new vision of an old friend. CAMKII, HAX-1, HRC, HSP20, PKA, PP1, SR
85  2014 Protein changes contributing to right ventricular cardiomyocyte diastolic dysfunction in pulmonary arterial hypertension. CamKIIdelta, Don, PAH, PKA, RV
86  2014 TGF-beta1-induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis. EMFs, EoE, ESM
87  2014 The role of CaMKII regulation of phospholamban activity in heart disease. HF, SR
88  2013 Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban. ---
89  2013 Arrhythmogenic right ventricular dysplasia/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriers. ARVD/C, TFC
90  2013 Co-expression of SERCA isoforms, phospholamban and sarcolipin in human skeletal muscle fibers. SLN
91  2013 Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a. CHOP, ER, GLP-1, GRP78, SERCA2a
92  2013 HNO enhances SERCA2a activity and cardiomyocyte function by promoting redox-dependent phospholamban oligomerization. SERCA2a, SR, WT
93  2013 Left-dominant arrhythmogenic cardiomyopathy in a large family: associated desmosomal or nondesmosomal genotype? AC, LV, RV
94  2013 Loss of the AE3 Cl(-)/HCO(-) 3 exchanger in mice affects rate-dependent inotropy and stress-related AKT signaling in heart. AE3, FFR, HCM
95  2013 Molecular mechanisms underlying the rapid arrhythmogenic action of bisphenol A in female rat hearts. BPA, CAMKII, PKA
96  2013 Nebivolol prevents desensitization of beta-adrenoceptor signaling and induction of cardiac hypertrophy in response to isoprenaline beyond beta1-adrenoceptor blockage. SERCA2a
97  2013 Phospholamban knockout breaks arrhythmogenic Ca⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice. endo, PLN-KO, SCWs, VTs
98  2013 Recurrent and founder mutations in the Netherlands-Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy. ---
99  2013 Sarco(endo)plasmic reticulum calcium ATPase (SERCA) inhibition by sarcolipin is encoded in its luminal tail. SERCA, SLN
100  2013 Structural dynamics and topology of phosphorylated phospholamban homopentamer reveal its role in the regulation of calcium transport. SERCA